Methionine sulfoxide
|
Basic information |
| Metabolite name | Methionine sulfoxide |
 | HMDB0002005 |
 |
C02989 |
 |
158980 |
| Synonyms | L-Methionine S-oxide |
| No. of studies | 7 |
|
Basic information |
| Metabolite name | Methionine sulfoxide |
| HMDB0002005 |
|
C02989 |
|
158980 |
| Synonyms | L-Methionine S-oxide |
| No. of studies | 7 |
|
Relationship between Methionine sulfoxide and depression (count: 7) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M087 | Type2 | ketamine group 2-h vs. baseline | Plasma | Human | Up |
| Study M1056 | Type2 | maternal separation + beraprost group vs. maternal separation group | Serum | Sprague-Dawley rat | Down |
| Study M115 | Type1 | MDD group vs. control group | Plasma | Human | Up |
| Study M613 | Type2 | CSDS susceptible + imipramine group vs. CSDS + vehicle group | Nucleus accumbens | C57BL/6 J mouse | Down |
| Study M741 | Type2 | MDD group, post vs. before SSRI treatment | Plasma | Human | Up |
| Study M908 | Type3 | post-ketamine treatment vs. baseline | Plasma | Human | Up |
| Study M911 | Type1 | CUS group vs. control group | Serum | Sprague-Dawley rat | Up |